Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma

Conditions: High Risk of Recurrence Interventions: Drug: Lenvatinib 10 mg Sponsors: Chang Gung Memorial Hospital; Ministry of Health and Welfare, Taiwan Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials